2024-11-18 08:38:26
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
Health/ 2023-07-22
Excellent 12-Month Results from SELUTION...

GENEVA,May 31,2023-- 12-month results from the SELUTION SFA trial have been presented at the Japan EndovascularTreatment (JET) Conference in...

Aravax doses first patient in Phase 2 peanut allergy clinical trials
Health/ 2023-07-22
Aravax doses first patient in Phase 2 pe...

MELBOURNE,Australia,June 1,2023--The first patient has been dosed in a Phase 2 study (AVX-201) being run by biotechnology company Aravax,whi...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release